PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 18 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanolic extracts improved atopic dermatitis-like skin lesions in vivo [PMID: 29932162]
Extracts from dried flowering tips showed anti-allergic effects in rats by reducing systemic anaphylactic shock and histamine release [PMID: 27446332]
Polysaccharides inhibited hepatoma growth in tumour-bearing mice [PMID: 24653548]
Vitexicarpin induced dose- and time-dependent cell death in human osteosarcoma MG63 cells via apoptosis [PMID: 38612399]
Extracts were effective in vitro against A. niger, C. albicans, B. subtilis, and S. aureus [PMID: 29504922]
Evidence summary
PubMed sources
- 1.PMID: 27446332 (2016) — Anti-allergic effect of Artemisia extract in rats. · Experimental and therapeutic medicine
- 2.PMID: 29932162 (2018) — Ethanolic Extracts of Artemisia apiacea Hance Improved Atopic Dermatitis-Like Skin Lesions In Vivo and Suppressed TNF-Alpha/IFN-Gamma⁻Induced Proinflammatory Chemokine Production In Vitro. · Nutrients
- 3.PMID: 29504922 (2018) — Evaluation of in-vitro antimicrobial activity of Artemisia apiacea H. and Scutellaria baicalensis G. extracts. · Journal of medical microbiology
- 4.PMID: 38612399 (2024) — Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma. · International journal of molecular sciences
- 5.PMID: 33041391 (2020) — Coronaviruses and Nature's Pharmacy for the Relief of Coronavirus Disease 2019.